ArticleHealth science reports2026
Predictive Accuracy of the 1-h HACOR Score for Identifying Non-Invasive Ventilation Failure in COPD Patients With Acute Hypercapnic Respiratory Failure: A Prospective Observational Study.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Chronic obstructive pulmonary disease (COPD) is frequently complicated by acute hypercapnic respiratory failure (AHRF) requiring non-invasive ventilation (NIV). Early identification of NIV failure is important, as delayed recognition may worsen outcomes. This study evaluated the predictive utility of the 1-h HACOR score for early identification of NIV failure in COPD patients. Methods: A prospective observational study was conducted at the National Institute of Diseases of the Chest and Hospital, Dhaka, from May 2022 to September 2023. Ninety-two patients of acute exacerbations of COPD with AHRF were purposively enrolled. Clinical parameters and HACOR scores were recorded at baseline and 1 h after NIV initiation. NIV failure was defined as death or need for intubation, classified as early (< 48 h) or late (≥ 48 h). Results: About 13.1% patients experienced NIV failure. The HACOR score decreased significantly at 1 h of NIV initiation in the success group (8.16 ± 4.52 to 3.38 ± 2.93; Conclusions: The HACOR score was a simple and reliable bedside tool for early prediction of NIV failure in patients with acute exacerbation of COPD complicated by AHRF. Its routine use may facilitate timely reassessment and escalation of respiratory support, although larger multicenter studies are needed for further validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.